Cloud-clone
SKU(재고 관리 코드):PAQ201Hu01
Polyclonal Antibody to Aldose Reductase Like Protein 1 (ARL1)
Polyclonal Antibody to Aldose Reductase Like Protein 1 (ARL1)
Immunohistochemistry: 5-20µg/mL;1:30-120
Immunocytochemistry: 5-20µg/mL;1:30-120
Optimal working dilutions must be determined by end user.
Product No.
PAQ201Hu01
Organism Species
Homo sapiens (Human).
Source
Polyclonal antibody preparation
Host
Rabbit
Potency
n/a
Ig Type
IgG
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Label
None
Immunogen
RPQ201Hu01-Recombinant Aldose Reductase Like Protein 1 (ARL1)
Buffer Formulation
0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
Traits
Liquid
Concentration
0.5mg/ml
Organism Species More
Rattus norvegicus (Rat)
Applications
WB
If the antibody is used in flow cytometry, please check FCM antibodies.
UOM
20µl 100µl 200µl 1ml 10ml
SPECIFITY
The antibody is a rabbit polyclonal antibody raised against ARL1. It has been selected for its ability to recognize ARL1 in immunohistochemical staining and western blotting.
USAGE
Western blotting: 0.01-2µg/mL
Immunohistochemistry: 5-20µg/mL
Immunocytochemistry: 5-20µg/mL
Optimal working dilutions must be determined by end user.
STORAGE
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
| Magazine | Citations |
| Head & neck | Increased salivary AKR1B10 level: association with progression and poor prognosis of oral squamous cell carcinoma Pubmed: 30430672 |
| International Journal of Medical Sciences | AKR1B10 Inhibitor Epalrestat Facilitates Sorafenib-Induced Apoptosis and Autophagy Via Targeting the mTOR Pathway in Hepatocellular Carcinoma Pubmed: 32547320 |
| Scientific Reports | Plasma Insulin/Erythrocytic Aldose Reductase Ratio as a Predictor for Hepatocellular Carcinoma Among Type II Diabetics and Hepatitis C Virus-Infected … |
| Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
| RPQ201Hu01 | Recombinant Aldose Reductase Like Protein 1 (ARL1) | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAQ201Hu01 | Polyclonal Antibody to Aldose Reductase Like Protein 1 (ARL1) | WB |
| MAQ201Hu21 | Monoclonal Antibody to Aldose Reductase Like Protein 1 (ARL1) | WB; IHC; ICC; IP. |
| SEQ201Hu | ELISA Kit for Aldose Reductase Like Protein 1 (ARL1) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMQ201Hu | Magnetic Luminex Assay Kit for Aldose Reductase Like Protein 1 (ARL1) ,etc. | Magnetic Luminex Assay for Antigen Detection. |
Share
